YY1 and colorectal cancer: TLCD2-1 promotes the expression of YY1 mRNA by targeting miR-193A-5p, thus regulating the colorectal cancer immune infiltrating microenvironment.[69] LINC00899 mainly exists in the cytoplasm and is highly expressed, which is associated with poor prognosis in patients.